Asthma Medicine May Hold the Key for Parkinson's Disease
Why Salbutamol?
Parkinson’s Disease is still pretty evasive, but scientists know that a globs of the protein a-synuclein build up in the brain cells and may even kill these brain cells. Scientists have gone through countless and tireless efforts to speed up the disappearance of this dangerous protein, or at the very least keep it from building up. Clemens Scherzer, a neurologist and genomes at Harvard Medical School and his colleagues agreed to try going about the treatment in a different way. “We wanted to find a drug that could turn down the production of a-synuclein,” explains Scherzer. It makes sense, doesn’t it? Why treat the build up when it is better to treat the source?
